Last: | $ |
---|---|
Change Percent: | 0.17% |
Open: | $3.49 |
Close: | $3.5161 |
High: | $3.6999 |
Low: | $3.43 |
Volume: | 57,158 |
Last Trade Date Time: | 02/12/2020 04:43:27 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $3.49 | $3.5161 | $3.6999 | $3.43 | 57,158 | 02-12-2020 |
$ | $3.41 | $3.51 | $3.8562 | $3.40 | 180,847 | 02-11-2020 |
$ | $3.82 | $3.55 | $3.82 | $3.4353 | 101,534 | 02-10-2020 |
$ | $3.80 | $3.85 | $3.906 | $3.53 | 417,495 | 02-07-2020 |
$ | $6.38 | $4.12 | $6.40 | $3.92 | 7,756,715 | 02-06-2020 |
$ | $3.22 | $3.13 | $3.32 | $3.11 | 4,285 | 02-05-2020 |
$ | $3.12 | $3.32 | $3.34 | $3.1049 | 19,373 | 02-04-2020 |
$ | $3.05 | $3.22 | $3.22 | $3.00 | 22,211 | 02-03-2020 |
$ | $3.0511 | $3.039 | $3.10 | $3.00 | 29,144 | 01-31-2020 |
$ | $3.08 | $3.11 | $3.20 | $3.05 | 18,009 | 01-30-2020 |
$ | $3.27 | $3.16 | $3.27 | $3.03 | 36,058 | 01-29-2020 |
$ | $3.40 | $3.17 | $3.40 | $3.06 | 73,758 | 01-28-2020 |
$ | $3.11 | $3.15 | $3.25 | $3.0065 | 34,357 | 01-27-2020 |
$ | $3.35 | $3.29 | $3.3871 | $3.00 | 107,328 | 01-24-2020 |
$ | $3.57 | $3.37 | $4.10 | $3.27 | 367,536 | 01-23-2020 |
$ | $3.49 | $3.38 | $3.49 | $3.35 | 13,297 | 01-22-2020 |
$ | $3.53 | $3.49 | $3.54 | $3.32 | 53,135 | 01-21-2020 |
$ | $3.74 | $3.70 | $3.92 | $3.371 | 228,331 | 01-20-2020 |
$ | $3.74 | $3.70 | $3.92 | $3.371 | 227,874 | 01-17-2020 |
$ | $3.37 | $3.92 | $4.87 | $3.1165 | 1,036,498 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
JanOne Inc. Company Name:
JAN Stock Symbol:
NYSE Market:
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...
JanOne Regains Compliance with Nasdaq's Listing Requirements PR Newswire LAS VEGAS , March 15, 2024 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain , today...